Medical News

Visual PCNL - A Safe and Effective Alternative to Conventional PCNL in Treatment of Renal Stones

Safety and efficacy of visual percutaneous nephrolithotomy (PCNL) in the treatment for renal stones was demonstrated in this retrospective study....

17 Jul, 2019

Email this page
Injecting Botulinum Toxin A into the Urethral Sphincter in Patients with Underactive Bladder – An Effective and Safe Method

A new retrospective study was conducted in China to evaluate the safety and efficacy of botulinum toxin A (BTX-A) injection into the urethral...

16 Jul, 2019

Email this page
Combination of Enzalutamide and Cisplatin Effective in Urothelial Carcinoma of Bladder

A recent study detected androgen receptor (AR) expression in a significant percentage of male patients with muscle invasive bladder cancer (MIBC)....

12 Jul, 2019

Email this page
RLP for Patients with Staghorn Renal Stones and Concurrent UTI

The efficacy and safety of retroperitoneal laparoscopic pyelolithotomy (RLP) with prolonged renal posterior lower segment incision for patients with...

08 Jul, 2019

Email this page

Key Trials

L-Carnitine and L-Acetylcarnitine, Beneficial in Men with Idiopathic Oligoasthenozoospermia

The formulation with L-carnitine (LC) and its active form L-acetylcarnitine exerted beneficial effects on the sperm motility, vitality and DNA...

Vibegron: New Therapeutic Option for Improving Nocturia in Overactive Bladder

Treatment with vibegron was associated with reduction in the frequency of nocturnal voiding, increase in the volume per nocturnal void and volume of...

Alfuzosin or Tamsulosin Might Improve Resolution of Urinary Retention Secondary to Benign Prostatic Obstruction

The evidence on the management of patients with urinary retention secondary to benign prostatic obstruction (UR/BPO) with pharmacological and non-...

Efficacy of Intravesical Instillation of Onabotulinum Toxin A in Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome is Limited

A systematic review and meta-analysis concluded that intravesical instillation of onabotulinum toxin-A (OBTX-A) had limited efficacy with...

Slide Library

Tadalafil (Tadaflo)

Erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH), are prevalent disorders in middle-aged and older men...

Email this page
Cranberry + D-mannose (Cranfit)

Around 50% of women experience at least one episode of UTI at some point in their lifetime and recurrent UTI occur in about 20-40% of women....

Email this page
Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Solifenacin succinate (Soliact)

The overall prevalence of overactive bladder (OAB) in men and women over the age of 40 years is 16.6%. Anticholinergic therapy is currently a...

Email this page

Our Publications

Update on Urolithiasis: Evaluation of Relation between Renal Papillary Abnormalities with Stone Composition and Description into a New Classification by Flexible Ureteroscopy

This update on urolithiasis described the incidence of papillary abnormalities in patients undergoing flexible ureteroscopy and its relation with...

Update on Urolithiasis: Evaluation of the Association of Obesity with Perioperative Outcomes following PCNL in Patients with Kidney Stones

This update on urolithiasis evaluated the association of obesity with adverse outcomes following percutaneous nephrolithotomy.

UTI: Physician Update

Physician update (issue 3) takes you through the recent news & information related to Urinary Tract Infections (UTI) followed by the various...

Role of Pyridoxine in Management of Urolithiasis

This literature provides information on role of pyridoxine in prevention of recurrence of calcium oxalate stones.

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...


Explore >>

Currently there is no content under this category.


Which testosterone preparation do you prefer in your patients with late onset hypogonadism?
Testosterone Cypionate/Enanthate
17% (1 vote)
Testosterone undecanoate injection
50% (3 votes)
Testosterone decanoate + testosterone isocaproate + testosterone phenpropionate + testosterone propionate injection
17% (1 vote)
Oral testosterone undecanoate
17% (1 vote)
Testosterone gel
0% (0 votes)
Total votes: 6